Literature DB >> 22433994

Objective measures of physical functional capacity warrant exploration to complement or replace the subjective physician estimated performance status.

Guru Sonpavde1, Nicholas J Vogelzang, Matthew D Galsky, Vasudevan A Raghavan, Suresh Daniel.   

Abstract

Performance status, a measure of physical functioning, can be influenced by several undefined physician and patient-related factors, and is inherently subjective. Although disappointing results in phase 3 trials may reflect a lack of improved outcomes due to biological mechanisms, a confounding effect of imbalances of physical functioning cannot be excluded in the context of modest increments in antitumor activity. Therefore, performance status estimation may complicate drug development, and an objective measure of physical reserve is desirable and may complement or outperform performance status. We explore and discuss attractive candidates for objective measures of physical functioning.

Entities:  

Mesh:

Year:  2012        PMID: 22433994     DOI: 10.1097/COC.0b013e3182019f03

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  7 in total

1.  Are patient-reported outcomes of physical function a valid substitute for objective measurements?

Authors:  J A J Douma; H M W Verheul; L M Buffart
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

2.  Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment.

Authors:  Hánah N Rier; Agnes Jager; Marieke C Meinardi; Joost van Rosmalen; Marc C J M Kock; Peter E Westerweel; Marija Trajkovic; Stefan Sleijfer; Mark-David Levin
Journal:  Support Care Cancer       Date:  2017-12-15       Impact factor: 3.603

3.  Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.

Authors:  Jemima T Collins; Simon Noble; John Chester; Helen E Davies; William D Evans; Jason Lester; Diane Parry; Rebecca J Pettit; Anthony Byrne
Journal:  BMC Cancer       Date:  2015-07-24       Impact factor: 4.430

Review 4.  The assessment and impact of sarcopenia in lung cancer: a systematic literature review.

Authors:  Jemima Collins; Simon Noble; John Chester; Bernadette Coles; Anthony Byrne
Journal:  BMJ Open       Date:  2014-01-02       Impact factor: 2.692

5.  The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.

Authors:  Jemima T Collins; Simon Noble; John Chester; Helen E Davies; William D Evans; Daniel Farewell; Jason F Lester; Diane Parry; Rebecca Pettit; Anthony Byrne
Journal:  Support Care Cancer       Date:  2017-07-18       Impact factor: 3.603

6.  Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer.

Authors:  Joeri A J Douma; Henk M W Verheul; Laurien M Buffart
Journal:  BMC Cancer       Date:  2018-10-29       Impact factor: 4.430

7.  Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials.

Authors:  Joeri A J Douma; Sonja Zweegman; Mieke Alberts; Sandy Kruyswijk; Niels C W J van de Donk; Myra van Linde; Laurien M Buffart; Henk M W Verheul
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.